| scholarly article | Q13442814 |
| P2093 | author name string | Filippo Acconcia | |
| Maria Marino | |||
| Anna Trentalance | |||
| P2860 | cites work | The lipid phosphatase activity of PTEN is critical for its tumor supressor function | Q22007981 |
| The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate | Q24317714 | ||
| Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway | Q24653458 | ||
| A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
| Linkage of rapid estrogen action to MAPK activation by ERalpha-Shc association and Shc pathway activation | Q28214415 | ||
| Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse | Q28252945 | ||
| PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells | Q28363087 | ||
| Multiple phosphoinositide 3-kinase-dependent steps in activation of protein kinase B | Q28646131 | ||
| New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway | Q29616144 | ||
| A nonclassical estrogen membrane receptor triggers rapid differential actions in the endocrine pancreas | Q32064845 | ||
| PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model | Q32069431 | ||
| Non-transcriptional action of oestradiol and progestin triggers DNA synthesis. | Q33890864 | ||
| Steroids conjugated to bovine serum albumin as tools to demonstrate specific steroid neuronal membrane binding sites. | Q33921734 | ||
| PI3-kinase inhibition: a target for drug development? | Q34011982 | ||
| Distinct nongenomic signal transduction pathways controlled by 17beta-estradiol regulate DNA synthesis and cyclin D(1) gene transcription in HepG2 cells. | Q34168767 | ||
| Estrogens and cell-cycle regulation in breast cancer | Q34336956 | ||
| Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis | Q34371260 | ||
| PKB/AKT: functional insights from genetic models | Q34389540 | ||
| Cellular functions of plasma membrane estrogen receptors | Q34605439 | ||
| Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium | Q35136963 | ||
| Estrogen induction of the cyclin D1 promoter: involvement of a cAMP response-like element | Q35644045 | ||
| Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling | Q35754878 | ||
| Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells | Q35846108 | ||
| Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain | Q36818855 | ||
| Estrogen receptor-alpha detected on the plasma membrane of aldehyde-fixed GH3/B6/F10 rat pituitary tumor cells by enzyme-linked immunocytochemistry | Q38322118 | ||
| Immunolocalisation of oestrogen receptor beta in human tissues | Q38466031 | ||
| Effects of oestrogens on cell proliferation and cell cycle kinetics. A hypothesis on the cell cycle effects of antioestrogens | Q40151163 | ||
| 17beta-Estradiol promotes the up-regulation of SR-BII in HepG2 cells and in rat livers. | Q40784361 | ||
| Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis. | Q40894248 | ||
| Differential effects of estradiol and estradiol-BSA conjugates | Q40920935 | ||
| The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells | Q40993616 | ||
| The significance of heregulin in breast cancer tumor progression and drug resistance | Q41126011 | ||
| Orphan receptor hepatocyte nuclear factor-4 antagonizes estrogen receptor alpha-mediated induction of human coagulation factor XII gene | Q42463195 | ||
| Inducible regulatory elements in the human cyclin D1 promoter | Q42498965 | ||
| Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. | Q42991716 | ||
| Estrogen regulation of cyclin D1 gene expression in ZR-75 breast cancer cells involves multiple enhancer elements | Q43643514 | ||
| beta-estradiol stimulation of DNA synthesis requires different PKC isoforms in HepG2 and MCF7 cells | Q43652288 | ||
| Estradiol-induced IP(3) mediates the estrogen receptor activity expressed in human cells | Q43704087 | ||
| Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K. | Q43708526 | ||
| Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression | Q43709177 | ||
| Estrogens do not modify MAP kinase-dependent nuclear signaling during stimulation of early G(1) progression in human breast cancer cells. | Q43719902 | ||
| ERs associate with and regulate the production of caveolin: implications for signaling and cellular actions | Q43843581 | ||
| Evaluation of potential implication of membrane estrogen binding sites on ERE-dependent transcriptional activity and intracellular estrogen receptor-alpha regulation in MCF-7 breast cancer cells | Q43897870 | ||
| Rapid stimulation of the PI3-kinase/Akt signalling pathway in developing midbrain neurones by oestrogen. | Q43923550 | ||
| Estrogen memory effect in human hepatocytes during repeated cell division without hormone | Q44809266 | ||
| Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. | Q53399983 | ||
| The plasma membrane estrogen receptor: nuclear or unclear? | Q58875403 | ||
| Insulin-like growth factors and breast cancer | Q62267742 | ||
| Apolipoprotein C-II mRNA levels in primate liver. Induction by estrogen in the human hepatocarcinoma cell line, HepG2 | Q70077959 | ||
| Kinetics of estrogen-dependent modulation of apolipoprotein A-I synthesis in human hepatoma cells | Q70134339 | ||
| 17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells | Q71124075 | ||
| Transcriptional activation of the cyclin D1 gene is mediated by multiple cis-elements, including SP1 sites and a cAMP-responsive element in vascular endothelial cells | Q73054399 | ||
| Increased mitochondrial superoxide production in rat liver mitochondria, rat hepatocytes, and HepG2 cells following ethinyl estradiol treatment | Q73135830 | ||
| P433 | issue | 6 | |
| P921 | main subject | phosphorylation | Q242736 |
| P1104 | number of pages | 9 | |
| P304 | page(s) | 2583-2591 | |
| P577 | publication date | 2003-02-06 | |
| P1433 | published in | Molecular Biology of the Cell | Q2338259 |
| P1476 | title | Biphasic estradiol-induced AKT phosphorylation is modulated by PTEN via MAP kinase in HepG2 cells | |
| P478 | volume | 14 |
| Q43281811 | 17beta-Estradiol regulates the first steps of skeletal muscle cell differentiation via ER-alpha-mediated signals |
| Q44948703 | Bcl-x(S) induces an NGF-inhibitable cytochrome c release |
| Q58762425 | Beyond the Antioxidant Activity of Dietary Polyphenols in Cancer: the Modulation of Estrogen Receptors (ERs) Signaling |
| Q39963624 | CCL2 protects prostate cancer PC3 cells from autophagic death via phosphatidylinositol 3-kinase/AKT-dependent survivin up-regulation |
| Q33631719 | Clathrin Heavy Chain Interacts With Estrogen Receptor α and Modulates 17β-Estradiol Signaling |
| Q39863634 | Comparison of gene expression profiles in HepG2 cells exposed to arsenic, cadmium, nickel, and three model carcinogens for investigating the mechanisms of metal carcinogenesis |
| Q35969254 | Effects of Combination of Estradiol with Selective Progesterone Receptor Modulators (SPRMs) on Human Breast Cancer Cells In Vitro and In Vivo |
| Q40230900 | Effects of pharmacological concentrations of estrogens on growth of 3AO human ovarian cancer cells |
| Q38046498 | Estrogen in obesity-associated colon cancer: friend or foe? Protecting postmenopausal women but promoting late-stage colon cancer |
| Q33770684 | Estrogen rapidly activates the PI3K/AKT pathway and hypoxia-inducible factor 1 and induces vascular endothelial growth factor A expression in luminal epithelial cells of the rat uterus |
| Q64280861 | Estrogen receptor signaling mechanisms |
| Q47820890 | Estrogen receptor β-dependent Notch1 activation protects vascular endothelium against tumor necrosis factor α (TNFα)-induced apoptosis |
| Q36499769 | Estrogen signaling multiple pathways to impact gene transcription |
| Q92240915 | Estrogens and breast cancer: Mechanisms involved in obesity-related development, growth and progression |
| Q37616780 | Glycolysis and oxidative phosphorylation are essential for purinergic receptor-mediated angiogenic responses in vasa vasorum endothelial cells |
| Q33403307 | Homeobox gene HOPX is epigenetically silenced in human uterine endometrial cancer and suppresses estrogen-stimulated proliferation of cancer cells by inhibiting serum response factor |
| Q36236071 | Hormonal influences on cancer progression and prognosis |
| Q42042194 | Human myeloblastic leukemia cells (HL-60) express a membrane receptor for estrogen that signals and modulates retinoic acid-induced cell differentiation |
| Q41971722 | Inhibition of transfected PTEN on human colon cancer |
| Q36663178 | Leptin's mitogenic effect in human liver cancer cells requires induction of both methionine adenosyltransferase 2A and 2beta |
| Q37432589 | Luteinizing hormone-induced Akt phosphorylation and androgen production are modulated by MAP Kinase in bovine theca cells |
| Q100162255 | Membrane estrogen receptors bind SRC |
| Q34760746 | Molecular mechanisms of bladder outlet obstruction in transgenic male mice overexpressing aromatase (Cyp19a1). |
| Q40305115 | Normal human immune cells are sensitive to telomerase inhibition by Brassica-derived 3,3-diindolylmethane,partly mediated via ERα/β-AP1 signaling |
| Q36267925 | Nutritional flavonoids impact on nuclear and extranuclear estrogen receptor activities |
| Q54411913 | PTEN suppression promotes neurite development exclusively in differentiating PC12 cells via PI3‐kinase and MAP kinase signaling |
| Q33564705 | Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol |
| Q39841354 | Placenta growth factor is a survival factor for human malignant mesothelioma cells |
| Q36321931 | Rapid activation of ERK1/2 and AKT in human breast cancer cells by cadmium |
| Q35263224 | Rapid non-genomic signalling by 17β-oestradiol through c-Src involves mTOR-dependent expression of HIF-1α in breast cancer cells |
| Q35603632 | Redox signalling to nuclear regulatory proteins by reactive oxygen species contributes to oestrogen-induced growth of breast cancer cells |
| Q28396388 | Sustained proliferation in cancer: Mechanisms and novel therapeutic targets |
| Q35084708 | The Effects of 17β-estradiol in Cancer are Mediated by Estrogen Receptor Signaling at the Plasma Membrane. |
| Q36002446 | The elements of human cyclin D1 promoter and regulation involved |
| Q46424872 | The localization and non-genomic function of the membrane-associated estrogen receptor in oligodendrocytes. |
| Q34197932 | The pro-apoptotic effect of quercetin in cancer cell lines requires ERβ-dependent signals. |
| Q33928558 | Tyrosine phosphatase Shp2 mediates the estrogen biological action in breast cancer via interaction with the estrogen extranuclear receptor |
| Q37640131 | Xenoestrogens challenge 17β-estradiol protective effects in colon cancer |
Search more.